Characterization of myeloid-derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia

Hemasphere. 2024 Sep 23;8(9):e70005. doi: 10.1002/hem3.70005. eCollection 2024 Sep.

Nikoleta Bizymi^{1

2}, Athina Damianaki^{1

2}, Nikoletta Aresti^{1

2}, Anastasios Karasachinidis^{1

2}, Zacharenia Vlata³, Matthieu Lavigne⁴, Emmanuel Dialynas⁴, Niki Gounalaki⁴, Irene Stratidaki⁴, Grigorios Tsaknakis^{1

2}, Aristea Batsali^{1

2}, Irene Mavroudi^{1

2}, Maria Velegraki^{1

2}, Ioannis Sperelakis⁵, Charalampos Pontikoglou^{1

2}, Panayotis Verginis^{6

7}, Helen A Papadaki^{1

2}

¹ Hemopoiesis Research Laboratory, School of Medicine University of Crete Heraklion Greece.
² Department of Hematology University Hospital of Heraklion Heraklion Greece.
³ Institute of Molecular Biology and Biotechnology Foundation for Research and Technology Hellas (IMBB-FORTH) Heraklion Greece.
⁴ Genomics Facility, Institute of Molecular Biology and Biotechnology Foundation for Research and Technology Hellas (IMBB-FORTH) Heraklion Greece.
⁵ Department of Orthopedics University Hospital of Heraklion Heraklion Greece.
⁶ Laboratory of Immune Regulation and Tolerance, School of Medicine University of Crete Heraklion Greece.
⁷ Department of Laboratory Hematology University Hospital of Heraklion Heraklion Greece.

No abstract available